thrombindannelsesdygtige and thrombinholdige pharmaceutical preparations of active substance and medicinal products

• 1. 一种含有凝血酶抑制剂美拉加群的水性药物制剂,及该制剂在制备通过鼻内给药治疗血栓栓塞的药物中的用途 [P] . 中国专利： CN1711104A . 2005-12-21
• 2. 含有羧肽酶U抑制剂和凝血酶抑制剂的药物制剂 [P] . 中国专利： CN100518820C . 2009.07.29
• 3. Carbamic acid ester, a preparation method thereof, the use of these Esters to prepare a Medicine, the active substances of medicinal products based on these compounds and Pharmaceutical Preparations Containing them [P] . AR029931A1 . 2003-07-23

  机译： 氨基甲酸酯，其制备方法，这些酯类在制备药物中的用途，基于这些化合物的药物活性物质和含有它们的药物制剂

• 4. MUCOADHESIVE ZERFAL PHARMACEUTICAL PREPARATION FOR THE DISPOSAL OF ACTIVE SUBSTANCES IN VETERINARY AND HUMAN MEDICINAL PRODUCTS [P] . 德国专利： DE50213479D1 . 2009-06-04

  机译： 粘胶状小药房制剂，用于处理兽药和人用药品中的活性物质

• 5. PHARMACOLOGICAL ACTIVE SUBSTANCES, THEIR PREPARATION AND THEIR MEDICINAL PRODUCTS AND THEIR PHARMACEUTICAL COMPOSITIONS [P] . SE7806462L . 1979-02-09

  机译： 药理活性物质，其制备和药用产品以及其药理成分

• 1. Improving the bioavailability of pharmacologically active substances in pharmaceutical and cosmetic formulations [J] . Joachim Storsberg, Marcel W.Laughton, Martin Geyer, 亚洲药物制剂科学(英文) . 2016,第001期
• 2. Modern characterization techniques for pharmaceutical substances and products [J] . Mont Kumpugdee-Vollrath 亚洲药物制剂科学(英文) . 2016,第001期
• 3. Single-run reversed-phase HPLC method for determining sertraline content, enantiomeric purity, and related substances in drug substance and finished product [J] . Alessia Rosetti, Rosella Ferretti, Leo Zanitti, 药物分析学报（英文） . 2020,第006期
• 4. Potential metal impurities in active pharmaceutical substances and finished medicinal products - A market surveillance study [J] . Wollein Uwe, Bauer Bettina, Habernegg Renate, European journal of pharmaceutical sciences . 2015,第Null期
• 5. Chemical, pharmaceutical and biological information for medicinal products containing chemical and/or biological active substances [J] . Antonio Espinosa Ubeda Pharmaceuticals policy and law. . 2015,第1a2期
• 6. Understanding the risks associated with the use of new psychoactive substances (NPS): High variability of active ingredients concentration, mislabelled preparations, multiple psychoactive substances in single products [J] . ZamengoL., FrisonG., BettinC., Toxicology Letters: An International Journal Providing a Forum for Original and Pertinent Contributions in Toxicology Research . 2014,第1期
• 7. SCIENTIFIC BASES FOR DEVELOPMENT OF TECHNOLOGY OF KEY SEMIPRODUCTS IN PRODUCTION OF MEDICINAL PREPARATIONS OF PIPERIDIN [C] . Kunnaz Murzagulova, Murgul Turmukhanova International Symposium on Runaway Reactions, Pressure Relief Design and Effluent Handling American Institute of Chemical Engineers/American Chemical Society Management Conference . 2005
• 8. A study of medicinal plants grown in California compared to those in other habitats in regard to their pharmaceutical importance and active medicinal constituents. [D] . Arbogast, E. M. 1933
• 9. Conductomeric Evaluation of the Release Kinetics of Active Substances from Pharmaceutical Preparations Containing Iron Ions [O] . Anna Lisik, Witold Musiał 2019
• 10. DEVELOPMENT OF TECHNOLOGIES FOR OBTAINING ACTIVE PHARMACEUTICAL INGREDIENTS, MEDICINAL AND DIAGNOSTIC PREPARATIONS BASED ON LIPIDS IN UKRAINE [O] . Yuriy Krasnopolsky 2020
• 11. Guidance for Industry. Impurities: Residual Solvents in New Veterinary Medicinal Products, Active Substances and Excipients (Revision) [R] . 2011

• 1. Medicinal Mushroom Products:Nutriceuticals and/or Pharmaceuticals? [J] . CHANG Shuting . 食用菌学报 . 2009,第4期
• 2. Quick Single Run Capillary Zone Electrophoresis Determination of Active Ingredients and Preservatives in Pharmaceutical Products [J] . Marina Franco ,Renata Jasionowska . 美国分析化学（英文） . 2013,第3期
• 3. 基于药效团与分子对接筛选丹参药材中凝血酶抑制活性成分 [C] . WANG Xing ,王星 ,ZHANG Yan-ling . 全国中医药博士生学术交流会暨第四届全国中医药博士生优秀论文颁奖会议 . 2013
• 4. LC-MS检测结合多元统计分析表征丹参和川芎中的凝血酶及凝血因子Xa抑制剂 [A] . 杨艺瑶 . 2020